The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): -
Expected first date of trading: 21/05/2002
Market: AIM
Location of address at which admission document will be available: Seymour Pierce Limited 29/30 Cornhill London EC3V 3NF
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Seymour Pierce Limited
Nominated Broker (AIM Companies): Seymour Pierce Limited
Financial PR Advisors: -

Company details
Name Role
James Derrick Slater Executive Chairman
Terence Bond Deputy Chairman and Managing Director
Julian George Viggars Chief Operating Officer UK
Dr John Denis Broome Chief Operating Officer USA
Dr Richard Peter Dixey Non Executive Director
Christopher James Slater Non Executive Director
Henry John Mark Tompkins Non Executive Director

Facts and Figures
Fiscal year end: - -
Incorporated in: England and Wales
Website URL: http://
space
Description of business:
BioProjects International PLC is an investing company which provides capital and commercial and strategic advice to early stage biotechnology companies in the UK, the US and mainland Europe.

Person(s) interested:
tbc


BioProjects International PLC

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds